⌕
T. Rowe Price Biotech ETF · TDNA · Nasdaq
A sector position · not Tenet-scored
Compare
$23.91−3.13%At close
$23.91−0.77 (−3.13%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

T. Rowe Price Biotech ETF (TDNA) Expense Ratio

Sources Fund holdings disclosures Fund disclosuresHow we compute thisNot investment advice

A 0.55% expense ratio sounds abstract. Here's what it is versus its Healthcare peers, and what any fee actually costs you in real dollars over time.

Expense ratio vs category

0.55%$55 per $10,000/yr
TDNA0.55%
Category avg0.76%

Below category average. This fund costs about 0.72× the typical Healthcare peer's fee. Cheap for its category, though a plain broad-index fund can still cost less.

Peer set: US-listed Healthcare equity ETFs · fee point-in-time.

Fee-drag calculator · in dollars

Amount invested
Holding period
TDNA fee cost (0.55%)$9,474
If it charged category avg (0.76%)$12,921
You keep$3,446

Fee dollars over 20 years on $25,000, assuming 7%/yr growth. Dollarising the fee is what actually changes behaviour.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.